98%
921
2 minutes
20
The prevalence of tattoos in western countries is about 20%. Tattoo ink may contain carcinogenic compounds. The aim of this study was to investigate if tattoo exposure is associated with an increased risk of cutaneous squamous cell carcinoma in individuals. In this population-based case-control study, 2857 cases aged 20 to 60 years, diagnosed between 2014 and 2017, were identified in the Swedish Cancer Registry. Statistics Sweden identified 3 random age- and sex-matched controls per case from the Swedish Total Population Register using incidence-density sampling. In 2019, participants answered a questionnaire regarding lifestyle factors, including tattoos and sun habits. We used logistic regression to investigate if tattoo exposure was associated with the relative risk of cutaneous squamous cell carcinoma. 61% of the cases and 53% of the controls replied to the questionnaire. Among the 1600 cases and the 4551 controls that participated, 15.1% and 17.6% had at least one tattoo before the index date. We found no increased risk of cutaneous squamous cell carcinoma in tattooed compared with non-tattooed individuals (incidence rate ratio, 0.95; 95% confidence interval, 0.78-1.15). Tattoo exposure was not associated with the risk of cutaneous squamous cell carcinoma in this first study of the association. However, more epidemiologic studies are needed before consensus regarding a lack of association can be reached.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145309 | PMC |
http://dx.doi.org/10.1007/s10654-025-01230-z | DOI Listing |
JPRAS Open
September 2025
Research and Development Cell, Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
Laryngoscope
September 2025
Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Cancer Rep (Hoboken)
September 2025
Dermatology Department, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Background: Non-melanoma skin cancers (NMSC) are the most frequent cutaneous tumors globally. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) represent the most frequently encountered representatives of this group and may represent a diagnosis challenge in some circumstances of hard to differentiate tumors.
Aims: The aim of this study was to determine the factors that influence the diagnosis of NMSC and their impact.
Inn Med (Heidelb)
September 2025
Klinik für Innere Medizin - Hämatologie/Onkologie und Palliativmedizin, Ev. Stift St. Martin, Koblenz, Deutschland.
Pure white cell aplasia (PWCA) is a rare hematological condition characterized by the complete absence of granulocytes and myeloid precursor cells in the bone marrow. In this case report, we describe a 76-year-old patient with chronic lymphocytic leukemia (CLL) and cutaneous squamous cell carcinoma of the right upper eyelid who developed PWCA after treatment with the immune checkpoint inhibitor (ICI) cemiplimab. The PWCA is a rare side effect of checkpoint inhibitors.
View Article and Find Full Text PDFOral Oncol
September 2025
Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: Despite overexpression of EGFR in head/neck squamous cell carcinoma (HNSCC), cetuximab monotherapy has limited benefit. Lenvatinib is a multi-targeted receptor tyrosine kinase inhibitor with activity against FGFRs1-4, involved in resistance to EGFR inhibition. We evaluated lenvatinib in combination with cetuximab in recurrent/metastatic (R/M) HNSCC.
View Article and Find Full Text PDF